| Source HCPCS Code |
|
Target NDC Code |
J9061
Inj, amivantamab-vmjw, 2 MG
|
⇄
|
57894-0501-00
RYBREVANT 350 MG/7 ML VIAL
|
| Detail Information |
| Relationship Start Date |
01/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
7 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9061
Inj, amivantamab-vmjw, 2 MG
|
⇄
|
57894-0501-01
RYBREVANT 350 MG/7 ML VIAL
|
| Detail Information |
| Relationship Start Date |
01/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
7 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9061
Inj, amivantamab-vmjw
|
⇄
|
57894-0501-01
Rybrevant
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|